NCT00081809Phase 2Completed

A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma

Study sponsor: Agenus Inc. · AGEN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2005-06Actual
Enrollment · participants35
Source updated2023-09-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.